At Sammprada Hospital, doctors regularly test cancer patients for diabetes, enabling them to understand the biological link between the two diseases. We have endeavored to develop effective therapeutic strategies towards managing the co-morbid conditions of cancer and diabetes.

Impact of Diabetes on Cancer Treatment Outcomes

Co-morbid diabetes compromises cancer-related outcomes, including increasing the risk of mortality. This can influence the choice of cancer treatment regimen and dosage, thus resulting in a suboptimal approach with worse outcomes. It is crucial to effectively manage diabetes in cancer patients to reduce both the short and long-term complications, as well as treatment-related toxicities.

Oncodiabetology-Focused Preventive Care

Primary prevention strategies focus on common risk factors for cancer and diabetes, including obesity, inactivity, tobacco use, and alcohol. The diabetes management in cancer patients is individualized to each cancer patient, including the management of related co-morbidities (hypertension, dyslipidemia) and long-term complications. These impediments include metabolic alterations, dehydration, infections and sepsis, weight loss, delayed wound healing, and aggressive cancer growth.

Diabetes Assessment in the Oncodiabetology Clinic

At our oncodiabetology clinic, the diabetes-related complications are thoroughly evaluated before initiating anti-cancer treatment. These tasks are essential for selecting the right anti-cancer drugs and for assessing both nutritional status and overall metabolic control. Subsequently, effective interventions include glucose-lowering therapy and relevant medications. Whether due to pre-existing diabetes or cancer drug-induced diabetes, sustained clinic surveillance leads to early treatment, better care, proper nutritional management, and improved quality of life (QoL) for cancer patients. This integrated approach sets a new benchmark for diabetes treatment in Bangalore and cancer treatment in Bangalore.

Conclusion

At Sammprada, our cancer management protocol includes periodical assessment of diabetes-related biomarkers throughout the care plan and the follow-up period. The strategies include early initiation of antidiabetic therapy, comprehensive care, and efforts to improve the nutritional status and quality of life (QoL) of cancer patients.